FdaApplication
NDA 218171
Identifiers
- fda_app_no: NDA218171
Properties
| Property | Value |
|---|---|
| applicant_name | XCOVERY HOLDINGS INC |
| application_type | NDA |
| approval_date | 2024-12-18 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ENSACOVE | ENSARTINIB HYDROCHLORIDE | EQ 25MG BASE | CAPSULE;ORAL |
| ENSACOVE | ENSARTINIB HYDROCHLORIDE | EQ 100MG BASE | CAPSULE;ORAL |
2 products